Inga Laursen

1.7k total citations
48 papers, 1.4k citations indexed

About

Inga Laursen is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Inga Laursen has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 17 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Inga Laursen's work include Complement system in diseases (17 papers), Immune Cell Function and Interaction (12 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Inga Laursen is often cited by papers focused on Complement system in diseases (17 papers), Immune Cell Function and Interaction (12 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Inga Laursen collaborates with scholars based in Denmark, Netherlands and United Kingdom. Inga Laursen's co-authors include Gunnar Houen, Claus Koch, Michael Christiansen, Charlotte Sværke Jørgensen, A. E. Lykkesfeldt, P Briand, Peter Højrup, Magnus Christian Lydolph, Karen Duus and Anne E. Lykkesfeldt and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Inga Laursen

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inga Laursen Denmark 22 561 342 175 156 150 48 1.4k
Loren D. Fast United States 25 1.2k 2.2× 412 1.2× 183 1.0× 71 0.5× 304 2.0× 66 2.1k
Michelle Moore United States 23 647 1.2× 425 1.2× 333 1.9× 57 0.4× 80 0.5× 54 1.8k
Hongxiu Ji United States 17 411 0.7× 440 1.3× 267 1.5× 221 1.4× 302 2.0× 42 1.4k
Naomi McGovern United Kingdom 17 1.2k 2.1× 353 1.0× 264 1.5× 36 0.2× 156 1.0× 28 1.8k
Isabelle Magalhaes Sweden 22 590 1.1× 296 0.9× 410 2.3× 62 0.4× 256 1.7× 52 1.2k
Sharon O’Toole Ireland 23 219 0.4× 927 2.7× 370 2.1× 209 1.3× 170 1.1× 77 1.8k
N. N. Teng United States 21 497 0.9× 560 1.6× 300 1.7× 537 3.4× 265 1.8× 37 2.1k
Zhutian Zeng China 15 703 1.3× 339 1.0× 104 0.6× 45 0.3× 343 2.3× 22 1.4k
Nancy Wehner United States 22 464 0.8× 428 1.3× 224 1.3× 72 0.5× 207 1.4× 37 2.0k
Nina‐Beate Liabakk Norway 25 565 1.0× 1.2k 3.4× 431 2.5× 36 0.2× 259 1.7× 50 2.2k

Countries citing papers authored by Inga Laursen

Since Specialization
Citations

This map shows the geographic impact of Inga Laursen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Laursen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Laursen more than expected).

Fields of papers citing papers by Inga Laursen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inga Laursen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Laursen. The network helps show where Inga Laursen may publish in the future.

Co-authorship network of co-authors of Inga Laursen

This figure shows the co-authorship network connecting the top 25 collaborators of Inga Laursen. A scholar is included among the top collaborators of Inga Laursen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inga Laursen. Inga Laursen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlsen, Mona Aarenstrup, et al.. (2014). Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer. Scandinavian Journal of Clinical and Laboratory Investigation. 74(6). 477–484. 9 indexed citations
2.
Laursen, Inga, et al.. (2014). Development, Manufacturing and Characterization of a Highly Purified, Liquid Immunoglobulin G Preparation from Human Plasma. Transfusion Medicine and Hemotherapy. 41(3). 205–212. 10 indexed citations
3.
Svensson, Jannet, Stefanie Eising, Henrik B. Mortensen, et al.. (2011). High levels of immunoglobulin E and a continuous increase in immunoglobulin G and immunoglobulin M by age in children with newly diagnosed type 1 diabetes. Human Immunology. 73(1). 17–25. 11 indexed citations
4.
Simonsen, Anja Hviid, Sára Bech, Inga Laursen, et al.. (2010). Proteomic investigations of the ventriculo-lumbar gradient in human CSF. Journal of Neuroscience Methods. 191(2). 244–248. 19 indexed citations
5.
Pihl, Tina Holberg, Charlotte Sværke Jørgensen, Eric Santoni‐Rugiu, et al.. (2010). Safety Pharmacology, Toxicology and Pharmacokinetic Assessment of Human Gc Globulin (Vitamin D Binding Protein). Basic & Clinical Pharmacology & Toxicology. 107(5). 853–860. 7 indexed citations
6.
Brouwer, Nannette, F.N.J. Frakking, Marianne D. van de Wetering, et al.. (2009). Mannose-Binding Lectin (MBL) Substitution: Recovery of Opsonic Function In Vivo Lags behind MBL Serum Levels. The Journal of Immunology. 183(5). 3496–3504. 29 indexed citations
7.
Frakking, F.N.J., Nannette Brouwer, Marianne D. van de Wetering, et al.. (2009). Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. European Journal of Cancer. 45(4). 505–512. 32 indexed citations
8.
Bitsch, Mikael, et al.. (2009). Epidemiology of Chronic Wound Patients and Relation to Serum Levels of Mannan-binding Lectin. Acta Dermato Venereologica. 89(6). 607–611. 18 indexed citations
9.
Svendsen, Claus Bo, Tina Hummelshøj, Lea Munthe‐Fog, et al.. (2008). Ficolins and Mannose-Binding Lectin in Danish patients with sarcoidosis. Respiratory Medicine. 102(9). 1237–1242. 23 indexed citations
10.
Duus, Karen, Inga Laursen, Per Brinch Hansen, et al.. (2008). The chaperone and potential mannan‐binding lectin (MBL) co‐receptor calreticulin interacts with MBL through the binding site for MBL‐associated serine proteases. FEBS Journal. 275(3). 515–526. 33 indexed citations
11.
Jensen, Pia Hønnerup, Inga Laursen, Finn Matthiesen, & Peter Højrup. (2007). Posttranslational modifications in human plasma MBL and human recombinant MBL. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(3). 335–344. 17 indexed citations
12.
Jørgensen, Charlotte Sværke, et al.. (2007). Protein chemical characterization of Gc globulin (vitamin D-binding protein) isoforms; Gc-1f, Gc-1s and Gc-2. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(4). 481–492. 31 indexed citations
13.
Bang, Peter Fibiger, Inga Laursen, Klaus Thornberg, et al.. (2007). The pharmacokinetic profile of plasma-derived mannan-binding lectin in healthy adult volunteers and patients with Staphylococcus aureus septicaemia. Scandinavian Journal of Infectious Diseases. 40(1). 44–48. 22 indexed citations
14.
Laursen, Inga, et al.. (2007). Second‐generation nanofiltered plasma‐derived mannan‐binding lectin product: process and characteristics. Vox Sanguinis. 92(4). 338–350. 16 indexed citations
15.
Jørgensen, Charlotte Sværke, Frank Vinholt Schiødt, Benny Dahl, Inga Laursen, & Gunnar Houen. (2007). Comparison of rocket and crossed immuno‐electrophoresis assays for determination of the level of actin complexing of Gc globulin. Scandinavian Journal of Clinical and Laboratory Investigation. 67(7). 767–777. 8 indexed citations
16.
Jørgensen, Charlotte Sværke, et al.. (2006). Large‐scale purification and characterization of non‐glycosylated Gc globulin (vitamin D‐binding protein) from plasma fraction IV. Biotechnology and Applied Biochemistry. 44(1). 35–44. 13 indexed citations
17.
Jensen, Charlotte Harken, L. Drivsholm, Inga Laursen, & B. Teisner. (1999). Elevated Serum Levels of Fetal Antigen 1,a Member of the Epidermal Growth Factor Superfamily, in Patients with Small Cell Lung Cancer. Tumor Biology. 20(5). 256–262. 9 indexed citations
18.
Laursen, Inga & Anne E. Lykkesfeldt. (1992). Purification and characterization of an α1-antichymotrypsin-like 66 kDa protein from the human breast cancer cell line, MCF-7. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1121(1-2). 119–129. 16 indexed citations
19.
Lykkesfeldt, Anne E., Inga Laursen, & Per Briand. (1989). Regulation of the secretion of proteins synthesized by the human breast cancer cell line, MCF-7. Molecular and Cellular Endocrinology. 62(2). 287–296. 16 indexed citations
20.
Kjeldsen, Thomas, Inga Laursen, Anne E. Lykkesfeldt, P Briand, & Jesper Zeuthen. (1989). Monoclonal Antibodies Reactive with Components in Serum-Free Conditioned Medium from a Human Breast Cancer Cell Line (MCF-7). Tumor Biology. 10(4). 190–201. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026